A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients.
Sung Gwe AhnSoong June BaeHak Woo LeeChang Ik YoonJun Won KimIk Jae LeeJoon JeongPublished in: Breast cancer research and treatment (2018)
Targeted intra-operative radiotherapy using Intrabeam® is a safe procedure for Korean patients with breast cancer with an acceptable toxicity profile in the acute period.
Keyphrases
- phase ii study
- locally advanced
- liver failure
- minimally invasive
- end stage renal disease
- early stage
- respiratory failure
- radiation induced
- neoadjuvant chemotherapy
- chronic kidney disease
- ejection fraction
- newly diagnosed
- radiation therapy
- oxidative stress
- cancer therapy
- drug induced
- open label
- rectal cancer
- prognostic factors
- clinical trial
- patient reported outcomes
- intensive care unit
- drug delivery
- extracorporeal membrane oxygenation
- study protocol
- atrial fibrillation